Acer Therapeutics Inc.
NASDAQ:ACER
Overview | Financials
| Company Name | Acer Therapeutics Inc. |
| Symbol | ACER |
| Currency | USD |
| Price | 0.66 |
| Market Cap | 0 |
| Dividend Yield | 0% |
| 52-week-range | 0.55 - 4.56 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Christopher Schelling |
| Website | https://www.acertx.com |
An error occurred while fetching data.
About Acer Therapeutics Inc.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD



